Unknown

Dataset Information

0

Bivalent ligands promote endosomal trafficking of the dopamine D3 receptor-neurotensin receptor 1 heterodimer.


ABSTRACT: Bivalent ligands are composed of two pharmacophores connected by a spacer of variable size. These ligands are able to simultaneously recognize two binding sites, for example in a G protein-coupled receptor heterodimer, resulting in enhanced binding affinity. Taking advantage of previously described heterobivalent dopamine-neurotensin receptor ligands, we demonstrate specific interactions between dopamine D3 (D3R) and neurotensin receptor 1 (NTSR1), two receptors with expression in overlapping brain areas that are associated with neuropsychiatric diseases and addiction. Bivalent ligand binding to D3R-NTSR1 dimers results in picomolar binding affinity and high selectivity compared to the binding to monomeric receptors. Specificity of the ligands for the D3R-NTSR1 receptor pair over D2R-NTSR1 dimers can be achieved by a careful choice of the linker length. Bivalent ligands enhance and stabilize the receptor-receptor interaction leading to NTSR1-controlled internalization of D3R into endosomes via recruitment of β-arrestin, highlighting a potential mechanism for dimer-specific receptor trafficking and signalling.

SUBMITTER: Budzinski J 

PROVIDER: S-EPMC8433439 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Bivalent ligands promote endosomal trafficking of the dopamine D3 receptor-neurotensin receptor 1 heterodimer.

Budzinski Julian J   Maschauer Simone S   Kobayashi Hiroyuki H   Couvineau Pierre P   Vogt Hannah H   Gmeiner Peter P   Roggenhofer Anna A   Prante Olaf O   Bouvier Michel M   Weikert Dorothee D  

Communications biology 20210910 1


Bivalent ligands are composed of two pharmacophores connected by a spacer of variable size. These ligands are able to simultaneously recognize two binding sites, for example in a G protein-coupled receptor heterodimer, resulting in enhanced binding affinity. Taking advantage of previously described heterobivalent dopamine-neurotensin receptor ligands, we demonstrate specific interactions between dopamine D3 (D<sub>3</sub>R) and neurotensin receptor 1 (NTSR1), two receptors with expression in ove  ...[more]

Similar Datasets

| S-EPMC3530844 | biostudies-literature
| S-EPMC4468002 | biostudies-literature
| S-EPMC4297516 | biostudies-literature
| S-EPMC6187407 | biostudies-literature
| S-EPMC2809046 | biostudies-literature
| S-EPMC8065765 | biostudies-literature
| S-EPMC9862751 | biostudies-literature
| S-EPMC4234217 | biostudies-literature
| S-EPMC2668543 | biostudies-literature
| S-EPMC3804115 | biostudies-literature